Affiliation:
1. University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA
2. Analysis Group, Inc. Boston Massachusetts USA
3. Merck & Co., Inc. Rahway New Jersey USA
Abstract
ObjectivesThis study aimed to assess whether disease‐free survival (DFS) may serve as a predictor for long‐term survival among patients with intermediate‐high risk or high risk renal cell carcinoma (RCC) post‐nephrectomy when overall survival (OS) is unavailable.MethodsThe Surveillance, Epidemiology and End Results‐Medicare database (2007–2016) was used to identify patients with non‐metastatic intermediate‐high risk and high risk RCC post‐nephrectomy. Landmark analysis and Kendall's τ were used to evaluate the correlation between DFS and OS. Multivariable regression models were used to quantify the incremental OS post‐nephrectomy associated with increased time to recurrence among patients with recurrence, adjusting for baseline covariates.ResultsA total of 643 patients were analyzed; mean age of 75 years; >95% of patients had intermediate‐high risk RCC at diagnosis; 269 patients had recurrence post‐nephrectomy. For patients with versus without recurrence at the landmark points of 1, 3, and 5 years post‐nephrectomy, the 5‐year OS were 37.0% versus 70.1%, 42.3% versus 72.8%, and 53.2% versus 78.6%, respectively. The Kendall's τ between DFS and OS post‐nephrectomy was 0.70 (95% CI: 0.65, 0.74; p < 0.001). After adjusting for baseline covariates, patients with one additional year of time to recurrence were associated with 0.73 years longer OS post‐nephrectomy (95% CI: 0.40, 1.05; p < 0.001).ConclusionThe significant positive association of DFS and OS among patients with intermediate‐high risk and high risk RCC post‐nephrectomy from this study supports the use of DFS as a potential predictor of OS for these patients when OS data are immature.
Reference26 articles.
1. American Cancer Society.Survival rates for kidney cancer [Internet].2021. Available from:https://www.cancer.org/cancer/kidney‐cancer/detection‐diagnosis‐staging/survival‐rates.html. Accessed 6 May 2021.
2. Cancer statistics, 2020
3. Grading of renal cell carcinoma
4. Validation of risk factors for recurrence of renal cell carcinoma: results from a large single‐institution series;Mijn JC;PLoS One,2019
5. Renal Cell Carcinoma: Diagnosis and Treatment, 1994–2003
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献